Novel targeted therapies and vaccination strategies for mesothelioma.
about
Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.Fowlpox-based survivin vaccination for malignant mesothelioma therapyTemsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients.Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma.
P2860
Novel targeted therapies and vaccination strategies for mesothelioma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel targeted therapies and vaccination strategies for mesothelioma.
@en
Novel targeted therapies and vaccination strategies for mesothelioma.
@nl
type
label
Novel targeted therapies and vaccination strategies for mesothelioma.
@en
Novel targeted therapies and vaccination strategies for mesothelioma.
@nl
prefLabel
Novel targeted therapies and vaccination strategies for mesothelioma.
@en
Novel targeted therapies and vaccination strategies for mesothelioma.
@nl
P2860
P1476
Novel targeted therapies and vaccination strategies for mesothelioma.
@en
P2093
Anna K Nowak
Mamta Bagia
P2860
P2888
P304
P356
10.1007/S11864-011-0149-1
P577
2011-06-01T00:00:00Z